With millions of dollars of investment from pharmaceutical companies, this meeting focuses on the exciting research field that everyone is watching: cancer metabolism. Given the pharmaceutical industry’s heavy investment into the research of cancer metabolism, seize your chance to take part in the fast growing community which is translating the Warburg phenomenon into a new generation of cancer therapies. With the agenda designed by cutting edge research with experts at GSK, AstraZeneca, Genentech, Myrexis, Cornerstone and Warburg Glycomed, the World Cancer Metabolism summit is unchallenged in its industry relevance. It is designed to be specific and relevant to cancer metabolism and will deliver solutions to current issues faced by drug developers.